ArticleMedical science monitor : international medical journal of experimental and clinical research2020

Inhibitor of Differentiation 1 (ID1) Facilitates the Efficacy of Sorafenib in Non-Small Cell Lung Cancer Cells through Suppressing Epithelial to Mesenchymal Transition.

Yu-Xiao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.